Print this page

[42] Property, plant and equipment 

XLS

 

 

 

 

 

 

€ million

Land, land rights and buildings, including buildings on third-party land

Plant and machinery

Other facilities, operating and office equipment

Construction in progress and advance payments to vendors and contractors

Total

Cost at January 1, 2012

2,476.0

2,825.2

915.2

729.0

6,945.4

Changes in scope of consolidation

2.9

3.3

0.1

6.3

Additions

8.8

28.3

33.2

260.0

330.3

Disposals

–42.0

–89.8

–67.1

–0.9

–199.8

Transfers

221.9

293.8

31.0

–557.6

–10.9

Classification as held for sale or transfer to a disposal group

Currency translation

–16.1

–16.4

–5.7

–1.4

–39.6

December 31, 2012

2,651.5

3,044.4

906.7

429.1

7,031.7

 

 

 

 

 

 

Accumulated depreciation and impairment losses January 1, 2012

–954.2

–2,040.2

–663.2

–174.4

–3,832.0

Changes in scope of consolidation

Depreciation

–108.7

–199.4

–88.3

–396.4

Impairment losses

–16.0

–21.5

–4.1

–2.5

–44.1

Disposals

26.5

82.7

64.1

0.1

173.4

Transfers

–4.6

1.2

1.6

–1.8

Reversals of impairment losses

1.4

1.4

Classification as held for sale or transfer to a disposal group

Currency translation

4.0

12.6

4.8

21.4

December 31, 2012

–1,051.6

–2,164.6

–685.1

–176.8

–4,078.1

 

 

 

 

 

 

Net carrying amount as of December 31, 2012

1,599.9

879.8

221.6

252.3

2,953.6

 

 

 

 

 

 

Cost at January 1, 2013

2,651.5

3,044.4

906.7

429.1

7,031.7

Changes in scope of consolidation

Additions

8.0

15.1

25.0

360.4

408.5

Disposals

–376.2

–63.5

–46.6

–10.3

–496.6

Transfers

186.9

253.0

63.0

–512.1

–9.2

Classification as held for sale or transfer to a disposal group

–0.8

–4.4

–2.7

–7.9

Currency translation

–56.9

–43.8

–20.4

–3.6

–124.7

December 31, 2013

2,412.5

3,200.8

925.0

263.5

6,801.8

 

 

 

 

 

 

Accumulated depreciation and impairment losses January 1, 2013

–1,051.6

–2,164.6

–685.1

–176.8

–4,078.1

Changes in scope of consolidation

Depreciation

–108.9

–187.8

–85.2

–381.9

Impairment losses

–29.5

–11.0

–0.8

–0.4

–41.7

Disposals

148.6

62.1

44.7

9.7

265.1

Transfers

–54.2

–108.4

–0.4

166.6

3.6

Reversals of impairment losses

4.7

0.4

5.1

Classification as held for sale or transfer to a disposal group

0.4

1.8

1.9

4.1

Currency translation

20.7

33.0

15.5

69.2

December 31, 2013

–1,069.8

–2,374.5

–709.4

–0.9

–4,154.6

 

 

 

 

 

 

Net carrying amount as of December 31, 2013

1,342.7

826.3

215.6

262.6

2,647.2

Impairment losses totaled € 41.7 million in fiscal 2013 (2012: € 44.1 million). Of this total, € 30.3 million was recorded as one-time items under other operating expenses. Of this amount, € 25.3 million was attributable to the buildings of Merck Serono site in Geneva, Switzerland as well as an additional € 3.9 million to further buildings of the Merck Serono division. These impairment losses were within the context of the “Fit for 2018” transformation and growth program.

Furthermore, impairments on property, plant and equipment in the amount of € 11.4 million were recognized in other operating expenses under impairment losses. Of this, € 7.4 million was attributable to the Performance Materials division and related to a production plant in the Pigments business. In addition, impairments were recorded for property, plant and equipment in the Merck Serono division in the amount of € 2.5 million and in the Merck Millipore division of € 1.2 million.

In connection with the forthcoming sale of the Discovery and Development Solutions business field of the Merck Millipore division to Eurofins Scientific S.A., Luxembourg, property, plant and equipment was reclassified to “assets held for sale” as of December 31, 2013, in the amount of € 3.8 million.

The total amount of property, plant and equipment used to secure financial liabilities was immaterial. Total government grants and subsidies in connection with investments in property, plant and equipment during the fiscal year amounted to € 2.9 million (2012: € 12.3 million).

Directly allocable borrowing costs on qualified assets in the amount of € 0.4 million were capitalized.

Property, plant and equipment also included assets that were leased. The total value of capitalized leased assets amounted to € 9.3 million (2012: € 10.1 million) and the corresponding obligations amounted to € 7.7 million (2012: € 9.8 million) (see Note [61]).

The carrying amounts of assets classified as finance leases were as follows:

XLS

 

 

 

€ million

Dec. 31, 2013

Dec. 31, 2012

Land and buildings

7.1

8.8

Vehicles

1.4

0.9

Other property, plant and equipment

0.8

0.4

 

9.3

10.1

© Merck KGaA, Darmstadt, Germany, Last Update 2014/03/06